Condition
Childhood Mortality
Total Trials
5
Recruiting
0
Active
0
Completed
5
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 5/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
100%
5 trials in Phase 3/4
Results Transparency
80%
4 of 5 completed with results
Key Signals
4 with results100% success
Data Visualizations
Phase Distribution
5Total
P 4 (5)
Trial Status
Completed5
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT03676764Phase 4CompletedPrimary
Community Health Azithromycin Trial in Burkina Faso
NCT03682653Phase 4CompletedPrimary
Neonates and Azithromycin, an Innovation in the Treatment of Children in Burkina Faso
NCT02047981Phase 4CompletedPrimary
Mortality Reduction After Oral Azithromycin: Mortality Study
NCT03338244Phase 4CompletedPrimary
Mortality Reduction After Oral Azithromycin Contingency: Mortality Study
NCT02048007Phase 4CompletedPrimary
Mortality Reduction After Oral Azithromycin: Morbidity Study
Showing all 5 trials